Bringing the fundamentals into focus…
Back to Axsome Therapeutics, Inc.
How Axsome Therapeutics, Inc. stacks up
AXSM · against 185 other Healthcare companies of similar size
Growth
92/ 100
Near the top of its peers.
Ranked #17 of 186 · scores higher than 91% of peers
Bars: peers in each 10-point band of the growth score26 peers with a growth score of 90–100, including AXSM · Click a bar to see the companies
Why growth scores 92?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over the last year: stronger than 91% of peers. Revenue growth: 56.9% vs peer median 6.1%
- faster revenue growth over three years: stronger than 94% of peers. 3-year revenue growth: 62.0% vs peer median 5.8%
Metric by metric
Position: dot = AXSM, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | AXSM | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 186 reported | 56.9% | 9.7% | 90% | 33% | |
| Earnings per share growthHigher is better · 128 reported | Not reported | 12.8% | — | — | 33% |
| 3-year revenue growthHigher is better · 180 reported | 62.0% | 10.2% | 93% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around AXSM| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.8B USD | 99 | 31 | |
| 2 | 37.3B HKD (≈$4.8B) | 98 | 90 | |
| 2 | 3.8B USD | 98 | 71 | |
| 2 | 9.3B USD | 98 | 64 | |
| 5 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 12 | 10.5B USD | 94 | 56 | |
| 14 | 9.4B USD | 93 | 70 | |
| 14 | 4.2B USD | 93 | 44 | |
| 14 | 9.2B USD | 93 | 39 | |
| 17 | 7.3B USD | 92 | 32 | |
| 17 | 10.0B USD | 92 | 64 | |
| 19 | 41.9B SEK (≈$4.2B) | 91 | 53 | |
| 19 | 6.0B USD | 91 | 32 | |
| 19 | 3.9B USD | 91 | 52 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score